Basem Abdelfattah, MD
Pain Medicine · Dallas, TXNPI 1467688853
Payments from drug & device makers
Across 459 payments — averaging $33.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$3K
- Biohaven Pharmaceutical Holding Company Ltd.$2K
- Spinal Simplicity, LLC$2K
- Nevro Corp.$1K
- Si-bone, Inc.$521
- plus $4K from 29 others
What the payments were for
- Consulting fees$1,60010%
- Travel & lodging$3042%
- Food & beverage$11,81577%
- Education$1,52710%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 114 | $3,997 |
| Abbott | 138 | $2,597 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $1,708 |
| Spinal Simplicity, LLC | 6 | $1,601 |
| Nevro Corp. | 24 | $1,056 |
| Si-bone, Inc. | 7 | $521 |
| Scilex Pharmaceuticals Inc. | 30 | $502 |
| Edwards Lifesciences | 1 | $400 |
| AbbVie(2 entities) | 22 | $367 |
| Collegium Pharmaceutical, Inc. | 21 | $328 |
| Vertiflex, Inc. | 3 | $256 |
| Arbor Pharmaceuticals, Inc. | 13 | $199 |
| Amgen(2 entities) | 9 | $190 |
| Boston Scientific | 4 | $185 |
| Azurity Pharmaceuticals, Inc. | 11 | $183 |
| Integra Lifesciences Corporation | 2 | $163 |
| VGI Medical, LLC | 1 | $150 |
| Pfizer | 8 | $148 |
| Heron Therapeutics, Inc. | 1 | $81 |
| Almatica Pharma LLC | 4 | $79 |
| Teva Pharmaceuticals USA, Inc. | 4 | $68 |
| Biohaven Pharmaceuticals, Inc. | 4 | $60 |
| Globus Medical | 3 | $55 |
| Novartis | 3 | $50 |
| Tersera Therapeutics LLC | 3 | $46 |
| Assertio Therapeutics, Inc. | 2 | $35 |
| Forte Bio-pharma LLC | 1 | $33 |
| Vertex | 2 | $32 |
| SPR Therapeutics, Inc | 2 | $31 |
| IBSA Pharma Inc. | 2 | $28 |
| Biodelivery Sciences International, Inc. | 2 | $25 |
| Vertos Medical, Inc. | 1 | $23 |
| Avanos Medical | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$1,527
- NURTEC ODT$1,504
- INTELLIS$1,137
- INTELLIS ADAPTIVESTIM$645
- iFuse Implant$414
- HemoSphere$400
- Senza Spinal Cord Stimulation System$281
- Proclaim Family of SCS IPGs$235
- Superion ISS$230
- ETERNA$172
- SiJoin, VerteLoc, CerLoc$150
- CODMAN CERTAS$142
- CUSA CLARITY$142
- DURAGEN DURAL GRAFT MATRIX$142
- DURASEAL EXACT SPINAL SEALANT SYSTEM$142
- HAKIM$142
- Vanta$138
- SUPERION$128
- Omnia$127
How this compares
$15,246 in reported general payments places this provider in the 80th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 49 | $32,450 |
| ZtlidoLidocaine | 37 | $23,646 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 932 | $23,032 |
| Buprenorphine | 33 | $7,127 |
| HorizantGabapentin Enacarbil | 12 | $6,813 |
| Gabapentin | 292 | $4,385 |
| Pregabalin | 141 | $2,452 |
| OxycontinOxycodone Hcl | 15 | $2,045 |
| Tramadol Hcl | 190 | $1,096 |
| Tizanidine Hcl | 162 | $1,007 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 71 | $971 |
| Cyclobenzaprine Hcl | 84 | $785 |
| Duloxetine Hcl | 48 | $718 |
| Methocarbamol | 73 | $637 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $505 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $328 | $32,45049 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $502 | $23,64637 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $199 | $6,81312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Dallas
- Muhammad ZulqarnainDallas$556K
- Amol PatwardhanDallas$177K
- Justin ThompsonDallas$45K
- Demaceo HowardDallas$39K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.